BridgeMD
New treatment option for Total Knee Arthroplasty\(TKA\)
Official title Use of Cryopressotherapy in Patiens Undergoing Total Knee Replacement to Improve Clinical Outcome
ClinicalTrials.gov ID: NCT07456787
What this study is testing
- What it's testing
- The purpose of this study is to evaluate the effectiveness of cryopressotherapy in patients undergoing total knee arthroplasty by assessing clinical improvement using the KOOS at 14 days after surgery. Analysis of the knee Range of Motion (ROM) in the preoperative phase, at the predischarge visit, and at the follow-up visit for suture removal performed 14 days after surgery.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Candidates for elective total knee arthroplasty surgery (indication determined solely by the Orthopedic Surgeon)
- Patients aged between 18 and 80 years (inclusive) for both groups
- Body Mass Index (BMI) between 18 and 35 kg/m²
- Willingness and ability to provide informed consent
- Patients with non-inflammatory degenerative knee joint disease, including osteoarthritis
You likely can't join if
- Use of medications that may interfere with muscle metabolism
- Bone metastases or diseases at the surgical site
- Presence or suspicion of infection at the knee
- Inability to provide informed consent
- Obesity (BMI ≥ 35 kg/m²)
- Patients requiring revision surgery of total knee arthroplasty
See the full eligibility criteria
- Candidates for elective total knee arthroplasty surgery (indication determined solely by the Orthopedic Surgeon)
- Patients aged between 18 and 80 years (inclusive) for both groups
- Body Mass Index (BMI) between 18 and 35 kg/m²
- Willingness and ability to provide informed consent
- Patients with non-inflammatory degenerative knee joint disease, including osteoarthritis
- Use of medications that may interfere with muscle metabolism
- Bone metastases or diseases at the surgical site
- Presence or suspicion of infection at the knee
- Inability to provide informed consent
- Obesity (BMI ≥ 35 kg/m²)
- Patients requiring revision surgery of total knee arthroplasty
- Patients with pacemakers and/or mechanical implants or those who may be affected by BIA interference
The study team makes the final eligibility decision.
Where it's taking place
- Milan, Italy, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Milan, Italy, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.